Pramlintide
Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects
AstraZeneca · Phase 2 · Completed · Enrollment 184
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Pramlintide acetate (AC137) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.